Clinical trials update from the Heart Failure Society of America: EMOTE, HERB-CHF, BEST genetic sub-study and RHYTHM-ICD

European Journal of Heart Failure

Volumn 6, Issue 7, 2004, Pages 953-955

  Lalukota, Krishna ^a   Cleland, John G F ^a   Ingle, Lee ^a   Clark, Andrew L ^a   Coletta, Alison P ^a  

^a UNIVERSITY OF HULL   (United Kingdom)

Author keywords

BEST genetic sub study; EMOTE; HERB CHF; RHYTHM ICD

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUCINDOLOL; CRATAEGUS EXTRACT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE; ENOXIMONE; INOTROPIC AGENT; NORADRENALIN; PHOSPHODIESTERASE INHIBITOR; PROPRANOLOL;

CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL TRIAL; EXPERIMENTAL THERAPY; GENETIC ANALYSIS; HEART FAILURE; HEMODYNAMICS; HOSPITALIZATION; HUMAN; MORTALITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RANDOMIZATION; SHORT SURVEY;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ARGININE; CARDIOTONIC AGENTS; CARDIOVASCULAR AGENTS; CRATAEGUS; ENOXIMONE; ENZYME INHIBITORS; EXERCISE TOLERANCE; HEART FAILURE, CONGESTIVE; HOMOZYGOTE; HUMANS; OXYGEN CONSUMPTION; PLANT EXTRACTS; PROPANOLAMINES; RANDOMIZED CONTROLLED TRIALS; RECEPTORS, ADRENERGIC, BETA-1; SOCIETIES, MEDICAL; STROKE VOLUME; SURVIVAL ANALYSIS; TREATMENT FAILURE; TREATMENT OUTCOME; UNITED STATES;

EID: 8844274873     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2004.10.003     Document Type: Short Survey

References (14)

1. A.J. Cowley, and A.M. Skene Treatment of severe heart failure: quantity or quality of life? A trial of enoximone. Enoximone investigators Br. Heart. J. 72 1994 226 230
2. B.D. Lowes, M. Higginbotham, and L. Petrovich For the enoximone study group. Low-dose enoximone improves exercise capacity in chronic heart failure J. Am. Coll. Cardiol. 36 2000 501 508
3. B.F. Uretsky, M. Jessup, and M.A. Konstam Multicentre trial of oral enoximone in patients with moderate to moderately severe congestive heart failure. Lack of benefit compared to placebo. Enoximone Multicentre Trial Group Circulation 82 1990 774 780
4. C.J. Holubarsch, W.S. Colucci, T. Meinertz, W. Gaus, and M. Tendera Survival and prognosis: investigation of Crataegus extract WS1442 in congestive heart failure (SPICE)-rationale study design and study protocol Eur. J. Heart. Fail. 2 2000 431 437
5. D. Schroder, D. Weiser, and P. Klein Efficacy of a homeopathic Crataegus preparation compared with usual therapy for mild (NYHA II) cardiac insufficiency: results of an observational cohort study Eur. J. Heart. Fail. 5 2003 319 326
6. L. Zanolla Letter to the Editor Eur. J. Heart. Fail. 6 2004 509
7. A.L. Clark, and A. Morice Letter to the editor Eur. J. Heart Fail. 6 2004 511
8. J. Niebauer Letter to the editor Eur. J. Heart. Fail. 6 2004 513
9. S.D. Anker Letter to the editor Eur. J. Heart. Fail. 6 2004 515
10. The beta blocker evaluation of survival trial investigators A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure N. Engl. J. Med. 344 2001 1659 1667
11. H.L. White, R.A. de Boer, A. Magbool, and D. Greenwood MERIT-HF Study Group. An evaluation of the beta-1 adrenergic receptor Arg389 Glypolymorphism in individuals with heart failure: a MERIT-HF sub-study. Eur. J. Heart. Fail. 5 2003 463 468
12. J.G. Cleland, J. Ghosh, N.K. Khan, S. Ghio, L. Tavazzi, and G. Kaye Multi-chamber pacing: a perfect solution for cardiac mechanical dyssynchrony Eur. Heart. J. 24 2003 384 390
13. M.R. Bristow, L.A. Saxon, and J. Boehmer For the COMPANION investigators. Cardiac resynchronisation therapy with or without an implantable defibrillator in advanced chronic heart failure N. Engl. J. Med. 350 2004 2140 2150
14. J.G. Cleland, J.C. Daubert, and E. Erdmann CARE-HF study steering committee and investigators. The CARE-HF study (cardiac resynchronisation in heart failure study) rationale, design and end points Eur. J. Heart. Fail. 3 2001 481 489